With a $1.2 billion dollar acquisition of Gracell Biotechnologies, pharmaceutical giant AstraZeneca has firmly entrenched itself in the Asian market. The company is not only expanding its footprint, but also broadening its scope with its foray into cell therapy—Gracell’s specialized offering. With
For patients living with Relapsed or Refractory Multiple Myeloma (RRMM), life revolves around treatment cycles, clinical trials, brief periods of good health, and the uncertainty of when they will be sick again. By definition, RRMM is a rare type of incurable blood cancer referred to as relapsed
In an era marked by unprecedented advancements in biomedical science and technology, personalized medicine has emerged as a transformative force within the biopharmaceutical industry. This introduction sets the stage for exploring how tailor-madepersonalized medicine is reshaping the landscape of
Biopharma supply chains have a far-reaching impact on health worldwide and should be managed accordingly. However, complexities in the manufacturing, distribution, and delivery of life-saving drugs are unavoidable—especially given the lingering effects of the pandemic and the current global
In an era characterized by heightened corporate accountability, the biopharmaceutical industry is no exception to the scrutiny surrounding Environmental, Social, and Governance (ESG) practices. In recent years, concerns about the environmental impact of biopharma operations have intensified,
According to the Mayo Clinic , cancer is a term used to describe a wide range of diseases where abnormal cells proliferate uncontrollably, infiltrating and damaging healthy tissues. Cancer can metastasize, spreading throughout the body and affecting more and more organs. Globally, cancer is now the
